Skip to content
Lower risk Drug recall · FDA · Published March 24, 2022

Preferred Pharmaceuticals recalls Econazole Nitrate Cream 1% due to manufacturing changes

Preferred Pharmaceuticals is recalling Econazole Nitrate Cream 1% (30g tube) because Teligent Pharma discontinued its stability study program, affecting product safety.

🇺🇸 FDA recall #D-0771-2022DrugPreferred Pharmaceuticals ›
Take action

Contact the company

Recalling firmPreferred Pharmaceuticals, Inc.1250 N Lakeview Ave Ste O · Anaheim, CA 92807-1801
✎ GovInfoNow plain-language explainer

Preferred Pharmaceuticals is recalling Econazole Nitrate Cream 1% (30g tube) because the manufacturer Teligent Pharma stopped its stability testing. This recall is for safety reasons related to the product's quality control. Read more at govinfonow.com/recall/35046-preferred-pharmaceuticals-recalls-econazole-nitrate-cream-1-due-to-manufacturing.

Source Summary by GovInfoNow · govinfonow.com/recall/35046-preferred-pharmaceuticals-recalls-econazole-nitrate-cream-1-due-to-manufacturing · Updated August 18, 2026 · FDA enforcement record: FDA #D-0771-2022

Cite this page

“Preferred Pharmaceuticals recalls Econazole Nitrate Cream 1% due to manufacturing changes.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35046-preferred-pharmaceuticals-recalls-econazole-nitrate-cream-1-due-to-manufacturing. Based on FDA recall #D-0771-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0771-2022%22&limit=1).

The FDA announced on March 24, 2022, that Preferred Pharmaceuticals, Inc. recalled Econazole Nitrate Cream due to current good manufacturing practice deviations. The firm initiated this voluntary Class II recall because manufacturer Teligent Pharma, Inc. is discontinuing its stability study program.

How to tell if you have it

  • Brand: Preferred Pharmaceuticals
  • Product: Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only
  • NDC: 68788-7406-03
  • Lot codes: A1122P, G1421N
  • Expiration date: 1/1/2023
  • Quantity: 41 Tubes
  • Distribution: California and Florida

The hazard

The recall covers all products within expiry because the manufacturing firm, Teligent Pharma, Inc., is discontinuing its stability study program. The FDA classified this as a Class II recall due to CGMP deviations.

Context

GovInfoNow's records show Preferred Pharmaceuticals, Inc. has 32 other recalls on record since August 15, 2018. Other recent recalls of similar products include Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues (September 28, 2026), Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), and Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (November 17, 2025). Other recent recalls of similar products include Shoolin Pharma Chem Tadalafil Recall: FDA Inspection Findings (August 3, 2026), Shoolin Pharma Chem Sildenafil Recall: FDA Inspection Findings (August 3, 2026), and Blaine Labs Recalls Antifungal Solution Due to Stability Testing Issues (April 8, 2026).

How to tell if you have this one

Check for the product name 'Econazole Nitrate Cream 1%', 30 gm tube, prescription-only, with manufacturer Teligent Pharma, Inc. on the label. The NDC code 68788-7406-03 and lot numbers A1122P or G1421N are also indicators.

  • Brand
    Preferred Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 68788-7406-03 and lot numbers A1122P or G1421N on the product label.

Where it went and when

Where it was distributed

Distributed in California and Florida.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “Product distributed in California and Florida.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California, Florida.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Mar 24, 202212. FDA classified it Class II: Apr 14, 202223. Published in FDA’s Enforcement Report: Apr 20, 202234. FDA terminated the recall: Nov 17, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Preferred Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0771-2022 (March 24, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0771-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA